Roche licensed a Chinese biotech's obesity drug in a deal worth up to $1.16 billion
- Chinese 近 90 天出现 146 次
- 上一次：同一天稍早 · OpenAI's CFO warned businesses that Chinese AI models pose cybersecurity risks
发生了什么
The Swiss drugmaker will pay up to $100 million upfront to license an RNAi therapy targeting fat tissue from Shanghai-based Rona Therapeutics
摘要按规则整理自下方来源原文